{"a": [["Folic acid administration reduces the progression of microalbuminuria", "2014"], ["Report of the expert committee on the diagnosis and classification of diabetes mellitus", "1999"], ["Standards of medical care in diabetes \u2010 2008", "2008"], ["Standards of medical care in diabetes \u2010 2010", "2010"], ["Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study", "2000"], ["Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)", "2003"], ["Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes", "2008"], ["Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", "1998"], ["The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats", "2003"], ["Analysis of metabolic parameters as predictors of risk in the RENAAL study", "2003"], ["High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures", "1991"], ["Prevention of incipient diabetic nephropathy by high\u2010dose thiamine and benfotiamine", "2003"], ["Thiamine may indirectly act as an antioxidant", "1997"], ["Benfotiamin prevents the consequences of hyperglycemia induced mitochondrial overproduction of reactive oxygen species and experimental diabetic retinopathy [abstract]", "2001"], ["Albuminuria and estimated glomerular filtration rate as predictors of diabetic end\u2010stage renal disease and death", "2011"], ["Diabetic nephropathy", "2008"], ["Aldosterone antagonists for preventing the progression of chronic kidney disease", "2014"], ["Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end\u2010products: comparison with aminoguanidine", "1996"], ["Biochemistry and molecular cell biology of diabetic complications", "2001"], ["Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8\u2010year follow\u2010up study", "1999"], ["Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes", "2001"], ["Contribution of polyol pathway to diabetes\u2010induced oxidative stress", "2003"], ["A coefficient of agreement for nominal scales", "1960"], ["Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long\u2010term follow\u2010up study of childhood onset type\u20101 diabetic patients", "2001"], ["The association of microalbuminuria and mortality in non\u2010insulin\u2010dependent diabetes mellitus. A systematic overview of the literature", "1997"], ["The pathogenesis of diabetic nephropathy", "2008"], ["Hyperglycemia\u2010induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor\u20101 expression by increasing Sp1 glycosylation", "2000"], ["Thiamin", "1993"], ["Reversal of lesions of diabetic nephropathy after pancreas transplantation", "1998"], ["Role of advanced glycation end products in diabetic nephropathy", "2003"], ["The course of kidney function in type 2 (non\u2010insulin\u2010dependent) diabetic patients with diabetic nephropathy", "1993"], ["Risk factors for development of incipient and overt diabetic nephropathy in patients with non\u2010insulin dependent diabetes mellitus: prospective, observational study", "1997"], ["Clinical review: the role of advanced glycation end products in progression and complications of diabetes", "2008"], ["Diabetic nephropathy: diagnosis, prevention, and treatment", "2005"], ["Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy", "2003"], ["Advanced glycation end\u2010products (AGEs) in hyperglycemic patients. October 2005", "2005"], ["Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype", "1995"], ["Measuring inconsistency in meta\u2010analyses", "2003"], ["Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated February 2011). The Cochrane Collaboration, 2011", "2011"], ["Smoking and progression of diabetic nephropathy in type 1 diabetes", "2003"], ["Advanced glycation end products and diabetic foot disease", "2008"], ["Accumulation of fructosyl\u2010lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin\u2010induced diabetic rats", "2003"], ["KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease", "2007"], ["Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end\u2010products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions", "1996"], ["Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis", "2003"], ["The PRISMA statement for reporting systematic reviews and meta\u2010analyses of studies that evaluate health care interventions: explanation and elaboration", "1999"], ["Recent advances in diabetic nephropathy", "2004"], ["Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven\u2010year prospective study. The Microalbuminuria Collaborative Study Group", "1999"], ["Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non\u2010insulin\u2010dependent diabetic subjects", "1996"], ["Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin\u2010dependent diabetes mellitus patients", "1995"], ["Drug treatment for hypertensive patients in special situations: diabetes and hypertension", "1999"], ["Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients", "2001"], ["Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long\u2010term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial", "1999"], ["Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage", "2000"], ["A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA", "2008"], ["Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients", "1994"], ["Ethnicity and race influence the folate status response to controlled folate intakes in young women", "2004"], ["Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia", "1998"], ["Understanding the nature of renal disease progression", "1997"], ["Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin\u2010dependent diabetes mellitus", "1998"], ["Nephropathy in patients with type 2 diabetes mellitus", "1999"], ["Nephropathy of type\u20102 diabetes mellitus", "1998"], ["Smoking is associated with progression of diabetic nephropathy", "1994"], ["Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate", "1997"], ["Urinary albumin excretion rate and glomerular filtration rate in single\u2010kidney type 2 diabetic patients", "1998"], ["Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study", "2000"], ["The potential role of thiamine (vitamin B1) in diabetic complications", "2005"], ["High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease", "2007"], ["Diabetes\u2010induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+", "1992"], ["Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study", "1997"], ["Diabetic nephropathy in humans: pathologic diversity", "2011"], ["The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older\u2010onset diabetes mellitus", "2000"], ["Benfotiamine, a synthetic S\u2010acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid\u2010soluble thiamine disulfide derivatives", "2008"], ["Prostaglandin E1 for preventing the progression of diabetic kidney disease", "2010"], ["World Health Organization. Second report. Technical Report Series 646. 1980", "2014"], ["Diabetes mellitus. World Health Organization Technical Report Series 727. 1985", "2014"], ["Benfotiamine alleviates diabetes\u2010induced cerebral oxidative damage independent of advanced glycation end\u2010product, tissue factor and TNF\u2010alpha", "2006"], ["Protein glycation: creation of catalytic sites for free radical generation", "2001"]], "ex": [["Hyperhomocysteinaemia therapy in haemodialysis patients with combination of Vitamin B6, B12 and folic acid [abstract no: W467]", "2003"], ["The effect of vitamin B12 on total plasma homocysteine concentration in folate\u2010replete hemodialysis patients", "2003"], ["Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients", "2009"], ["Vitamin supplementation reduces the progression atherosclerosis in hyperhomocysteinemic renal transplant recipients [abstract]", "2002"], ["High dose\u2010B\u2010vitamin treatment of hyperhomocysteinemia in dialysis patients", "1996"], ["Vitamin B12 and folic\u2010acid as intravenous high\u2010dose vitamin therapy for hyperhomocysteinemia in hemodialysed ESRD\u2010patients: data of a prospective randomized controlled study [abstract no: SU\u2010PO1048]", "2003"], ["Effects of folic acid and vitamin B complex on serum C\u2010reactive protein and albumin levels in stable hemodialysis patients", "2007"], ["The effect of oral niacinamide on serum phosphorus levels in hemodialysis patients [abstract no: PUB430]", "2007"], ["Pharmacological dose of vitamin B12 is as effective as low\u2010dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients", "2009"], ["Hyperhomocysteinemia and alternate vitamin supplementation", "2007"], ["Homocysteine lowering effect of different multivitamin preparations in patients with end\u2010stage renal disease", "2001"], ["The effect of IV administration of sodium 2,3\u2010dimercaptopropane\u20101\u2010sulfonate (DMPS) and 8\u2010week high\u2010dosed IV vitamin B therapy on total plasma homocysteine (tHcy) in patients undergoing chronic hemodialysis (HD) [abstract no: PUB584]", "2008"], ["Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12", "2002"], ["Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes", "2005"], ["Alteration of thiamine pharmacokinetics by end\u2010stage renal disease (ESRD)", "1999"], ["High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine", "2000"], ["Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD", "2003"], ["Influence of a supplementation with vitamins on morbidity and mortality of ESRD patients: a multi\u2010center randomly designed double blinded intervention trial; Prismavit \u2010 prospective intervention study from Magdeburg with vitamins [abstract]", "2009"], ["Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate", "2001"], ["Homocysteine lowering with folic acid and B vitamins in vascular disease", "2006"], ["Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end\u2010stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end\u2010stage renal disease", "2003"], ["Vitamin B12 is effective in the treatment of hyperhomocysteinaemia in patients with ESRD [abstract no: 58]", "2003"], ["Is folate and vitamin B12 supplementation necessary in chronic hemodialysis patients with EPO treatment?", "1994"], ["Normalization of plasma homocystein (Hcy) levels in hyperhomocysteinemic hemodialysis patients by intravenous dosage of vitamins B6, B12 and folic acid [abstract no SA\u2010PO345]", "2004"], ["Vitamins supplementation effectiveness on hyperhomocysteinemia in hemodialyzed patients: a two\u2010year single\u2010blind randomized study [abstract no: SA\u2010PO344]", "2004"], ["Oral vitamin B(12) and high\u2010dose folic acid in hemodialysis patients with hyper\u2010homocyst(e)inemia", "2001"], ["Folic acid and B vitamins improve hyperhomocysteinemia\u2010induced cardiovascular risk profile in renal transplant recipients", "2007"], ["Vitamin supplement reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients [abstract no: F\u2010FC055]", "2002"], ["Hyperhomocysteinemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12 [abstract no: MP318]", "2005"], ["Clinical observation on treatment of diabetic peripheral neuphropathy by ginkgo leaf extract combined with active vitamin B12", "2004"], ["Water and fat soluble vitamins during erythropoietin (EPO) treatment(t) in haemodialyzed patients (HDP) [abstract]", "1995"], ["Methylenetetrahydrofolate reductase (MTHFR) gene polymorphism influences the efficacy of folic acid (FA) and vitamin b12 (B12) on hyperhomocyteinemia in hemodialysis (HD) patients [abstract]", "2003"], ["Comparative study of response to treatment with supraphysiologic doses of B\u2010vitamins in hyperhomocysteinemic hemodialysis patients", "2004"], ["The effect of high\u2010dose thiamine (B1) and pyridoxine (B6) on advanced glycation end products (AGEs) and oxidative stress markers in HD patients [abstract no: SU\u2010PO470]", "2004"], ["Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high\u2010flux haemodialysis and human recombinant erythropoietin", "2000"], ["Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes", "2006"], ["A prospective, randomized, placebo\u2010controlled study to evaluate the effect of combined treatment of folic acid and intravenous B\u2010complex vitamins on hyperhomocysteinemia in hemodialysis patients [abstract no: W\u2010PO40032]", "2005"], ["A randomised placebo controlled trial of intramuscular vitamin B12 (hydroxyocobalamin) for the treatment of hyperhomocysteinemia in haemodialysis patients [abstract]", "2002"], ["Homocysteine\u2010lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients", "2007"], ["Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial", "2005"], ["Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients", "2008"], ["The influence of vitamin B6 supplementation on the bone marrow morphology in patients on regular haemodialysis treatment. A double\u2010blind study", "1979"], ["No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia", "2004"], ["Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?", "2000"], ["Hyperhomocysteinemia in hemodialysis patients: effects of 12\u2010month supplementation with hydrosoluble vitamins", "2000"], ["Can folate and vitamin B supplementation reduce total homocysteine levels and atherosclerosis in hemodialysis patients? [abstract no: SA\u2010PO472]", "2004"], ["Effect of vitamin B12 supplementation in serum total homocysteine and folate in patients with end\u2010stage renal failure [abstract]", "2001"], ["Vitamin B(6) therapy does not improve hematocrit in hemodialysis patients supplemented with iron and erythropoietin", "2001"], ["Treatment of hyperhomocysteinemia and endothelial dysfunction in renal\u2010transplant recipients with vitamin B", "2005"], ["The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients", "2009"]], "in": [["Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: a randomized controlled trial", "2009"], ["A double\u2010blind, randomized, placebo\u2010controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy", "2010"], ["Vitamin therapy for homocysteine accelerates loss of renal function in diabetic kidney disease [abstract no: SA\u2010FC343]", "2009"], ["Pyridorin in type 2 diabetic nephropathy", "2012"], ["A phase 2 clinical investigation of pyridoxamine (Pyridorim\u2122) in type 1 and type 2 diabetic patients with overt diabetic nephropathy (PYR\u2010205/207) [abstract no: SU\u2010PO152]", "2004"], ["Investigation of the safety and efficacy of pyridoxamine (Pyridorin) in patients with diabetic nephropathy (PYR\u2010206) [abstract]", "2004"], ["A phase 2 clinical investigation of pyridoxamine (Pyridorim\u2122) in type 1 and type 2 diabetic patients with overt diabetic nephropathy (PYR\u2010205/207) [abstract no: SU\u2010PO152]", "2004"], ["High\u2010dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double\u2010blind placebo\u2010controlled pilot study", "2009"], ["The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria", "2008"]]}